52P: Does timing of immunotherapy infusion influence clinical outcomes in non-small cell lung cancer?I. Furtado, I. Guerreiro, Rosa M. Quinta‐Ferreira et al.|Journal of Thoracic Oncology|2025Cited by 0
42P Comparing survival outcomes in KRAS G12 vs KRAS G13-mutated metastatic colorectal cancer (mCRC): A 13-year cohort studyRosa M. Quinta‐Ferreira, João Gramaça, Luís Coelho et al.|ESMO Open|2025Cited by 0
Real-world efficacy and toxicity of immunotherapy in elderly patients with lung cancerF. Verdasca, I. Guerreiro, M. Seladas et al.|Journal of Geriatric Oncology|2025Cited by 0
Real-world treatment patterns and outcomes in elderly patients with metastatic colorectal a Portuguese single-center experienceRafael André Ferreira, J. Gramaça, I. Furtado et al.|Journal of Geriatric Oncology|2025Cited by 0